Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.32 |
| ▸ | TSPO | P30536 | 1/20 | 0.31 |
| ▸ | RXRA | P19793 | 1/20 | 0.30 |
| ▸ | RXRB | P28702 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25643859 | 0.93 | KDM4E (0.42) | KDM4EATML3MBTL1PTGER4TSPO | |
| SCHEMBL18541351 | 0.82 | KDM4E (0.38) | KDM4EATML3MBTL1PTGER4TSPO | |
| SCHEMBL18541228 | 0.82 | KDM4E (0.38) | KDM4EATML3MBTL1PTGER4TSPO | |
| SCHEMBL26216629 | 0.80 | AKR1C4 (0.35) | KDM4EATML3MBTL1 | |
| SCHEMBL23544138 | 0.80 | KDM4E (0.36) | KDM4EATML3MBTL1PTGER4TSPO | |
| SCHEMBL18126026 | 0.80 | L3MBTL1 (0.56) | KDM4EATML3MBTL1PTGER4TSPO | |
| SCHEMBL18541211 | 0.80 | KDM4E (0.42) | KDM4EATML3MBTL1PTGER4TSPO | |
| SCHEMBL21376302 | 0.79 | L3MBTL1 (0.55) | KDM4EATML3MBTL1PTGER4TSPO | |
| SCHEMBL24727169 | 0.78 | KIF11 (0.36) | KDM4EPTGER4TSPO | |
| SCHEMBL18541135 | 0.78 | L3MBTL1 (0.40) | KDM4EATML3MBTL1PTGER4TSPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230292608-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2023-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230292608-A1 | Organic Electroluminescent Materials and Devices | ICMT, INMT, PNMT | KDM4E 2262/4885ATM 1749/4885L3MBTL1 1157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.